A significant share of the global economy is dependent on the petroleum industry, which supplies a diverse range of products. Refined petroleum products become energy sources and materials for the ...

The Chinese biotech evaluated three different once-daily doses of its oral GLP-1 agonist, dubbed ASC30, in a phase 2 study of ...

GLP-1 receptor agonists (GLP-1 RAs) are transforming metabolic disease treatment, with analytical chemists playing a critical role in formulation, stability testing, and clinical trial support for ...

Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...

The 2026 update to the ADA’s Standards of Care in Diabetes introduces new guidance on a wide range of topics, including the ...

Speakers at the Institute for Value-Based Medicine event held September 18, 2025, in Nyack, New York, spoke about methods of ...

Ozempic (semaglutide) is a powerful and versatile drug, offering dual benefits: controlling blood sugar in type 2 diabetes, and facilitating weight loss as a secondary effect. While its primary ...

RNA-based therapeutics face challenges in bioanalysis, with experts recommending strategies to improve LC–MS performance and standardize ADME and DMPK practices. GLP-1 therapies require careful ...

A new study by the Centre for Chronic Disease Control (CCDC) for the first time concurrently estimated the daily salt and ...

The executives of the companies say by pairing weight-loss drugs such as semaglutide (Wegovy) and tirzepatide (Mounjaro) with ...

College students may plan an appointment during winter break and inquire about GLP-1 medications. What should a primary care ...